- Report
- March 2025
- 144 Pages
Global
From €3485EUR$3,999USD£3,026GBP
- Report
- April 2025
- 307 Pages
Global
From €3333EUR$3,825USD£2,894GBP
€3921EUR$4,500USD£3,405GBP
- Report
- January 2026
- 180 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- January 2026
- 188 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- January 2026
- 194 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- January 2026
- 184 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- January 2026
- 189 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- January 2026
- 186 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 188 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 184 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 182 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 189 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 198 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 186 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- September 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- April 2025
- 200 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- March 2025
- 175 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- January 2026
- 266 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 487 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- July 2025
- 350 Pages
Global
From €4312EUR$4,949USD£3,745GBP

Fluorine-18 (F-18) is a radioactive isotope used in Nuclear Medicine and Radiopharmacy. It is produced in a cyclotron and is used in positron emission tomography (PET) imaging. F-18 is used to diagnose and monitor a variety of diseases, including cancer, heart disease, and neurological disorders. It is also used to measure the effectiveness of treatments. F-18 has a short half-life of 110 minutes, so it must be produced and used quickly.
F-18 is used in a variety of radiopharmaceuticals, including Fluorodeoxyglucose (FDG), which is used to detect cancer. Other radiopharmaceuticals include Sodium Fluoride (NaF), which is used to detect bone metastases, and Fluoromisonidazole (FMISO), which is used to detect hypoxia.
The F-18 market is highly competitive, with many companies offering radiopharmaceuticals and PET imaging services. Some of the major players in the market include GE Healthcare, Siemens Healthineers, Mallinckrodt Pharmaceuticals, and Jubilant DraxImage. Show Less Read more